Warner Chilcott, Watson settle with direct purchasers in Loestrin 24 case
MLex Summary: Warner Chilcott and Watson Pharmaceuticals have reached a settlement with direct purchasers in a case accusing them of unlawfully delaying the market entry of generic versions of the drug...To view the full article, register now.
Already a subscriber? Click here to view full article